{
    "startDate": "2017-01-01",
    "endDate": "2017-06-30",
    "year": "2017",
    "quarter": "Q2",
    "symbol": "OPHT",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 140917000
            },
            {
                "label": "Available for sale securities with maturities of less than one year",
                "concept": "AvailableForSaleSecuritiesCurrent",
                "unit": "usd",
                "value": 55525000
            },
            {
                "label": "Due from Novartis Pharma AG",
                "concept": "ReceivablesLongTermContractsOrPrograms",
                "unit": "usd",
                "value": 674000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 2738000
            },
            {
                "label": "Current assets",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 199854000
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 1888000
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 46000
            },
            {
                "label": "Assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 201788000
            },
            {
                "label": "Accrued research and development expenses",
                "concept": "opht:AccruedResearchAndDevelopment",
                "unit": "usd",
                "value": 12687000
            },
            {
                "label": "Accounts payable and accrued expenses",
                "concept": "AccountsPayableAndAccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 6268000
            },
            {
                "label": "Deferred revenue",
                "concept": "DeferredRevenueCurrent",
                "unit": "usd",
                "value": 6646000
            },
            {
                "label": "Current liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 25601000
            },
            {
                "label": "Deferred revenue, long-term",
                "concept": "DeferredRevenueNoncurrent",
                "unit": "usd",
                "value": 200007000
            },
            {
                "label": "Royalty purchase liability",
                "concept": "RoyaltyGuaranteesCommitmentsAmount",
                "unit": "usd",
                "value": 125000000
            },
            {
                "label": "Liabilities and Stockholders\u2019 Deficit",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 350608000
            },
            {
                "label": "Preferred stock - $0.001 par value, 5,000,000 shares authorized, no shares issued or outstanding",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Common stock - $0.001 par value, 200,000,000 shares authorized, 35,932,179 and 35,733,276 shares issued and outstanding at June 30, 2017 and December 31, 2016, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 36000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 515615000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -664285000
            },
            {
                "label": "Accumulated other comprehensive loss",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -186000
            },
            {
                "label": "Beginning balance",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": -148820000
            },
            {
                "label": "Liabilities and Stockholders\u2019 Deficit",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 201788000
            }
        ],
        "cf": [
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -65326000
            },
            {
                "label": "Depreciation expense",
                "concept": "Depreciation",
                "unit": "usd",
                "value": 1393000
            },
            {
                "label": "Amortization of premium and discounts on investment securities",
                "concept": "InvestmentIncomeNetAmortizationOfDiscountAndPremium",
                "unit": "usd",
                "value": -137000
            },
            {
                "label": "Deferred income taxes",
                "concept": "DeferredIncomeTaxesAndTaxCredits",
                "unit": "usd",
                "value": -8000
            },
            {
                "label": "Exercise Price Range [Axis]",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 11052000
            },
            {
                "label": "Due from Novartis Pharma AG",
                "concept": "IncreaseDecreaseInContractReceivablesNet",
                "unit": "usd",
                "value": -2857000
            },
            {
                "label": "Income tax receivable",
                "concept": "IncreaseDecreaseInIncomeTaxesReceivable",
                "unit": "usd",
                "value": 52000
            },
            {
                "label": "Prepaid expense and other current assets",
                "concept": "opht:IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets",
                "unit": "usd",
                "value": -392000
            },
            {
                "label": "Accrued interest receivable",
                "concept": "IncreaseDecreaseInAccruedInterestReceivableNet",
                "unit": "usd",
                "value": -275000
            },
            {
                "label": "Other assets",
                "concept": "IncreaseDecreaseInOtherNoncurrentAssets",
                "unit": "usd",
                "value": -416000
            },
            {
                "label": "Accrued research and development expenses",
                "concept": "opht:IncreaseDecreaseInAccruedResearchAndDevelopment",
                "unit": "usd",
                "value": -34553000
            },
            {
                "label": "Accounts payable and accrued expenses",
                "concept": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
                "unit": "usd",
                "value": -5764000
            },
            {
                "label": "Deferred revenue",
                "concept": "IncreaseDecreaseInDeferredRevenue",
                "unit": "usd",
                "value": -3323000
            },
            {
                "label": "Operating Activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -92504000
            },
            {
                "label": "Purchase of marketable securities",
                "concept": "PaymentsToAcquireMarketableSecurities",
                "unit": "usd",
                "value": 12014000
            },
            {
                "label": "Maturities of marketable securities",
                "concept": "ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities",
                "unit": "usd",
                "value": 111459000
            },
            {
                "label": "Purchase of property and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Investing Activities",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": 99445000
            },
            {
                "label": "Proceeds from stock option/employee stock purchase plan exercises",
                "concept": "opht:ProceedsFromStockOptionAndEmployeeStockPurchasePlanExercises",
                "unit": "usd",
                "value": 46000
            },
            {
                "label": "Financing Activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 46000
            },
            {
                "label": "Net change in cash and cash equivalents",
                "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease",
                "unit": "usd",
                "value": 6987000
            },
            {
                "label": "Change in unrealized gain (loss) on available for sale securities, net of tax",
                "concept": "AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLossNetOfTax",
                "unit": "usd",
                "value": 26000
            }
        ],
        "ic": [
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -65326000
            },
            {
                "label": "Unrealized gain (loss) on available for sale securities, net of tax",
                "concept": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
                "unit": "usd",
                "value": 26000
            },
            {
                "label": "Other comprehensive income (loss)",
                "concept": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
                "unit": "usd",
                "value": 26000
            },
            {
                "label": "Comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -65300000
            },
            {
                "label": "Total collaboration revenue",
                "concept": "SalesRevenueServicesNet",
                "unit": "usd",
                "value": 3323000
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 47636000
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 21711000
            },
            {
                "label": "Operating expenses:",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 69347000
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -66024000
            },
            {
                "label": "Interest income",
                "concept": "InterestIncomeExpenseNonoperatingNet",
                "unit": "usd",
                "value": 722000
            },
            {
                "label": "Other loss",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": -22000
            },
            {
                "label": "Loss before income tax provision (benefit)",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                "unit": "usd",
                "value": -65324000
            },
            {
                "label": "Benefit from income taxes",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 2000
            },
            {
                "label": "Net loss per common share:",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -1.82
            },
            {
                "label": "Basic and diluted (in shares)",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 35831000
            }
        ]
    }
}